If you are considering ChondroFiller, it helps to understand how the injection is thought to work. ChondroFiller is a non-surgical, intra-articular collagen injection — a CE-marked, Class III collagen-based gel placed into the joint. In this article we explain, in plain terms, what it does once inside the joint, with realistic expectations throughout.

A Collagen Layer Within the Joint

ChondroFiller Liquid® is based on type I collagen, a natural protein. After being warmed to around body temperature, it is gently injected into the joint, where it sets into a soft gel. Rather than removing or cutting any tissue, the gel adds a biological collagen layer that may settle over worn joint surfaces.

By adding this layer, ChondroFiller may provide a protective interface between worn surfaces, helping to cushion the joint and reduce direct grinding and contact — which is why it is used to support joint preservation in osteoarthritis and joint wear.

A Cushioning, Mechanical Role

ChondroFiller's gel has mechanical properties that allow it to absorb load and adapt to the forces inside a joint (Weizel et al., 2020). This cushioning effect is part of how it may ease symptoms and protect the joint surfaces during movement.

Biological Potential — With Realistic Expectations

Because it is collagen-based, ChondroFiller has biological potential and works in harmony with the joint rather than simply masking pain. The device is acellular — meaning it contains no cells itself — and is designed to recruit the body's own progenitor cells into the scaffold, where they may contribute to tissue repair. However, it is best understood as a supportive, joint-preserving injection, not a guaranteed repair. It is not a cure for arthritis, does not reverse joint degeneration, and does not regrow a new joint surface. How much it helps, and for how long, varies from person to person.

What the Evidence Suggests

Published experience with collagen-matrix injections is encouraging but still developing. A 2023 study of an acellular collagen matrix injection for thumb-base osteoarthritis reported improvements in pain and grip strength (Corain et al., 2023), although responses vary and the same outcome cannot be assumed for every joint or patient. Larger, longer studies are needed to confirm how well and how durably it helps.

ChondroFiller Injection Versus Liquid Cartilage Surgery

It is worth understanding that ChondroFiller the injection and Liquid Cartilage are not the same thing. The ChondroFiller injection is a non-surgical, outpatient procedure — no theatre, no incision, no anaesthetic — suited to accessible lesions and smaller or less complex defects.

Liquid Cartilage is a different pathway entirely: it is the Lee Liquid Cartilage Protocol (LLC Protocol), a keyhole arthroscopic surgical technique developed by Professor Paul Y. F. Lee. During that procedure, the ChondroFiller scaffold is placed arthroscopically inside the joint and combined with biological adjuncts such as platelet-rich fibrin and platelet-rich plasma, plus mesenchymal stem cells where indicated. It involves a theatre, an anaesthetic, and a structured recovery programme. Liquid Cartilage is genuine minimally invasive surgery, used for larger or load-bearing cartilage defects in joints such as the knee, hip, shoulder, and ankle.

Which pathway — the injection or the surgical protocol — is appropriate depends on the size, location, and severity of the cartilage problem, as well as the patient's overall health and circumstances. A specialist assessment is needed to determine this.

Speaking to a Specialist

At the London Cartilage Clinic, Professor Paul Lee assesses your joint and symptoms and advises whether the ChondroFiller injection — or another option, including the Liquid Cartilage surgical protocol — may suit you, with clear and realistic expectations. The injection is a non-surgical, outpatient procedure, so there is no operation and no surgical recovery.

Conclusion

ChondroFiller works by adding a protective collagen layer within the joint that may cushion worn surfaces and reduce grinding, supporting joint preservation. It is a CE-marked, non-surgical injection with biological potential, not a cure. For advice tailored to you, consult a qualified healthcare professional.

References

Weizel, A., Distler, T., Schneidereit, D., & Friedrich, O. (2020). Complex mechanical behavior of human articular cartilage and hydrogels for cartilage repair. Acta Biomaterialia.

Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., & Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller® Liquid for trapeziometacarpal osteoarthritis. Cartilage.